Vident Advisory’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Sell |
36,865
-22,752
| -38% | -$62.1K | ﹤0.01% | 1566 |
|
|
2025
Q1 | $100K | Buy |
59,617
+16,326
| +38% | +$27.4K | ﹤0.01% | 1507 |
|
|
2024
Q4 | $70.6K | Buy |
43,291
+12,861
| +42% | +$21K | ﹤0.01% | 1417 |
|
|
2024
Q3 | $127K | Buy |
30,430
+1,491
| +5% | +$6.2K | ﹤0.01% | 1366 |
|
|
2024
Q2 | $158K | Buy |
28,939
+1,880
| +7% | +$10.3K | ﹤0.01% | 1318 |
|
|
2024
Q1 | $271K | Buy |
27,059
+1,889
| +8% | +$18.9K | 0.01% | 1088 |
|
|
2023
Q4 | $103K | Buy |
25,170
+14,924
| +146% | +$60.9K | ﹤0.01% | 1278 |
|
|
2023
Q3 | $39.7K | Buy |
+10,246
| New | +$39.7K | ﹤0.01% | 1239 |
|